AN69ST membranes adsorb nafamostat mesylate and affect the management of anticoagulant therapy: a retrospective study

BACKGROUND: In Japan, nafamostat mesylate (NM) is frequently used as an anticoagulant during continuous renal replacement therapy (CRRT). The dialyzer membrane AN69ST has been reported to adsorb NM and affect the management of anticoagulant therapy. However, the adsorbed amount has not yet been quan...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirayama, Takahiro, Nosaka, Nobuyuki, Okawa, Yasumasa, Ushio, Soichiro, Kitamura, Yoshihisa, Sendo, Toshiaki, Ugawa, Toyomu, Nakao, Atsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516335/
https://www.ncbi.nlm.nih.gov/pubmed/28729905
http://dx.doi.org/10.1186/s40560-017-0244-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516335/
https://www.ncbi.nlm.nih.gov/pubmed/28729905
http://dx.doi.org/10.1186/s40560-017-0244-x

Ejemplares similares